Crossmark

Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa

Crossref DOI link: https://doi.org/10.1016/j.eimc.2022.09.009

Published Print: 2023-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

López-Cerero, Lorena

Ballesta, Sofia

López, Cristina Elías

Sánchez-Yebra, Waldo

Rojo-Martin, María Dolores

Pascual, Alvaro
License Information

Text and Data Mining valid from 2023-12-01
More Information

This article is maintained by: Elsevier

Article Title: Evaluation of three commercial methods of susceptibility testing for ceftolozane/tazobactam against carbapenem-resistant Pseudomonas aeruginosa

Journal Title: Enfermedades Infecciosas y Microbiología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimc.2022.09.009

Content Type: simple-article

Copyright: © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.